Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. AL momani
Pcn32 - The Effectiveness and Safety of Switching From Orginal Filgrastim to Biosimilar Filgrastim in Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia: A Retrospective Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Expanded Access to Pembrolizumab From Cost-Savings Generated by Biosimilar Filgrastim (BIOSIM-FIL) in the Prophylaxis of Chemotherapy-Induced (FEBRILE) Neutropenia (CIN/FN): Simulation Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Expanded Access to Cancer Treatments From Conversion to Neutropenia Prophylaxis With Biosimilar Filgrastim-SNDZ
Future Oncology
Medicine
Cancer Research
Oncology
Pharmacokinetic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Comparison of the Pharmacodynamic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Filgrastim Therapy in a Child With Neutropenia Induced by Linezolid
International Journal of Clinical Pharmacy
Toxicology
Pharmacy
Pharmacology
Pharmaceutical Science
Risk and Consequences of Chemotherapy-Induced Neutropenic Complications in Patients Receiving Daily Filgrastim: The Importance of Duration of Prophylaxis
BMC Health Services Research
Health Policy
Quality Comparison of Biosimilar and Copy Filgrastim Products With the Innovator Product
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Filgrastim-SNDZ Debuts as the First Biosimilar Approved in United States
Journal of Community and Supportive Oncology
Oncology
Hematology
Cost-Effectiveness Analysis of Granulocyte Colony-Stimulating Factors for the Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Patients With Non-Hodgkin’s Lymphoma in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
